ArticleAnalytical and bioanalytical chemistry2026
Characterization of the biofilm landscape of Bacillus subtilis by spatial microproteomics.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Bulk proteomics has been demonstrated to differentiate subpopulations based on molecular phenotypes within bacterial colonies, yet advanced analyses by mass spectrometry imaging (MSI) hold even greater promise for the future. This technology can enable high-throughput spatial phenotyping that can directly visualize distinct components of various biomolecular mechanisms with high mass-resolving power in high spatial resolution analyses. Here, we applied MSI for intact protein imaging directly from thin cross-sections of a biofilm of Bacillus subtilis and after minimal preparation we detected more than 285 unique isotopic envelopes corresponding to unique proteoforms. We paired our MSI analyses with bulk top-down proteomics (TDP) to form extensive experimental libraries, which provided us with high confidence MSI annotations based upon isotopic matching to validated post-translational modifications (PTMs) and truncations. This joint application of MSI and TDP allowed us to describe the microscale spatial proteomic landscape within the B. subtilis biofilm. This study further demonstrated the feasibility of detecting differentiated subpopulations of cells through the identification of proteoforms of cannibalistic protein toxins as well as those involved in active sporulation to highly localized areas within the central and outermost periphery of the biofilm.
Indexed as
Identifiers
42437417What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.